This chapter examines influential finance figures who retain their mental acuity in later years, focusing on the interplay of genetics, lifestyle, and environment related to Alzheimer's and dementia. It also addresses the complexities of diagnosis, the need for specialized care, and the prospects of innovative pharmacological treatments, particularly GLP-1 drugs.